+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evolving screening and surveillance techniques for Barrett's esophagus

Evolving screening and surveillance techniques for Barrett's esophagus

World Journal of Gastroenterology 25(17): 2045-2057

Barrett's esophagus (BE) is a change in the esophageal lining and is known to be the major precursor lesion for most cases of esophageal adenocarcinoma (EAC). Despite an understanding of its association with BE for many years and the falling incidence rates of squamous cell carcinoma of the esophagus, the incidence for EAC continues to rise exponentially. In association with this rising incidence, if the delay in diagnosis of EAC occurs after the onset of symptoms, then the mortality at 5 years is greater than 80%. Appropriate diagnosis and surveillance strategies are therefore vital for BE. Multiple novel optical technologies and other advanced approaches are being utilized to assist in making screening and surveillance more cost effective. We review the current guidelines and evolving techniques that are currently being evaluated.

(PDF emailed within 1 workday: $29.90)

Accession: 066806536

Download citation: RISBibTeXText

PMID: 31114132

Related references

Screening and surveillance for Barrett esophagus. JAMA Internal Medicine 175(2): 159-160, 2015

How far to go? Screening and surveillance in Barrett's esophagus. American Journal of Managed Care 7(1 Suppl): S19-S26, 2001

Screening and surveillance of Barrett's esophagus. Current Gastroenterology Reports 11(3): 195-201, 2009

Surveillance and screening for Barrett esophagus and adenocarcinoma. Journal of Clinical Gastroenterology 39(4 Suppl 2): S33-S41, 2005

Screening for and surveillance of Barrett's esophagus is clinically indicated. Digestive Diseases 25(3): 197-202, 2007

Not all of Barrett's esophagus surveillance protocols are created equal: the dangers of retrospective outcome research in the treatment of Barrett's esophagus. Gastrointestinal Endoscopy 80(6): 1203, 2015

Barrett's Esophagus: Diagnosis, Screening, Surveillance, and Controversies. Gut and Liver 1(2): 93-100, 2007

The field effect in Barrett's esophagus: can we use it for screening and surveillance?. Endoscopy 45(12): 989-991, 2014

Screening and surveillance in Barrett's esophagus: a call to action. Clinical Gastroenterology and Hepatology 2(10): 861-864, 2004

Barrett's esophagus: update on screening, surveillance, and treatment. Archives of Internal Medicine 159(13): 1411-1416, 1999

Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?. Digestive Diseases and Sciences 63(8): 2094-2104, 2018

Point-Counterpoint: Screening and Surveillance for Barrett's Esophagus, Is It Worthwhile?. Digestive Diseases and Sciences: -, 2018

The use of optical coherence tomography in screening and surveillance of Barrett's esophagus. Clinical Gastroenterology and Hepatology 3(7 Suppl 1): S8-11, 2005

Another look at Barrett's esophagus. Current thinking on screening and surveillance strategies. Postgraduate Medicine 110(3): 57-8, 61-2, 65-8, 2001

Endoscopic screening and surveillance for Barrett's esophagus--clinical implications. Medgenmed 8(2): 66, 2006